单细胞测序在口腔鳞状细胞癌研究中的应用

doi:10.13701/j.cnki.kqyxyj.2024.09.002

摘要/Abstract

摘要： 口腔鳞状细胞癌是一种常见口腔恶性肿瘤,易转移、复发和产生耐药性。单细胞测序及在此基础上发展而来的空间转录组技术可以获取单个细胞水平的转录组信息,能更加深入地研究细胞种群、功能、变化和通讯。本文从细胞分型、肿瘤微环境、肿瘤侵袭和转移、治疗靶点与预后标志、免疫治疗、肿瘤内微生物等方面对单细胞测序技术在口腔鳞状细胞癌研究中的应用进行归纳总结,并探讨当前研究的不足与未来改进方向。

关键词: 单细胞测序, 口腔鳞状细胞癌, 肿瘤微环境, 治疗靶点, 免疫治疗

Abstract: Oral squamous cell carcinoma (OSCC) is a common malignant oral tumor with a tendency for metastasis, recurrence, and drug resistance. Current research on its mechanisms is insufficient. Single-cell sequencing and the spatial transcriptome technology can obtain transcriptome information at the single-cell level, enabling more in-depth research on cell populations, functions, changes, and communication. This paper provides a comprehensive summary of the application of single-cell sequencing technology in OSCC research areas such as cell typing, tumor microenvironment, tumor invasion and metastasis, therapeutic targets and prognostic markers, immune-targeted therapy, and intratumoral microbiota. It also points out the current deficiencies in research and suggests directions for future improvements.

Key words: single-cell sequencing, oral squamous cell carcinoma, tumor microenvironment, therapeutic targets, immunotherapy

乔颖婕, 黄心智. 单细胞测序在口腔鳞状细胞癌研究中的应用[J]. 口腔医学研究, 2024, 40(9): 762-766.

QIAO Yingjie, HUANG Xinzhi. Application of Single-cell Sequencing in Oral Squamous Cell Carcinoma Research[J]. Journal of Oral Science Research, 2024, 40(9): 762-766.

参考文献

[1] 林辰,张心雅,马伟燕,等.空间转录组学技术及其应用的研究进展[J].厦门大学学报(自然科学版),2022,61(3):506-516.
[2] Puram SV, Tirosh I, Parikh AS, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer [J]. Cell, 2017, 171(7): 1611-1624.e24.
[3] Yang W, Zhang S, Li T, et al. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway [J]. Acta Biochim Biophys Sin (Shanghai), 2022, 55(2):262-273.
[4] Zhang Q, Wang Y, Xia C, et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma [J]. Ann Transl Med, 2021, 9(12): 1017.
[5] Song H, Lou C, Ma J, et al. Single-cell transcriptome analysis reveals changes of tumor immune microenvironment in oral squamous cell carcinoma after chemotherapy [J]. Front Cell Dev Biol, 2022, 10: 914120.
[6] Chen J, Yang J, Li H, et al. Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma [J]. Mol Oncol, 2021, 15(4): 866-886.
[7] Peng Y, Xiao L, Rong H, et al. Single-cell profiling of tumor-infiltrating TCF1/TCF7⁺ T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer [J]. Oral Oncol, 2021, 119: 105348.
[8] Han N, Zhou D, Ruan M, et al. Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer [J]. Oral Oncol, 2023, 145: 106524.
[9] Lottin M, Soudet S, Fercot J, et al. Molecular landscape of the coagulome of oral squamous cell carcinoma [J]. Cancers (Basel), 2022, 14(2): 460.
[10] Li J, Chen S, Liao Y, et al. Arecoline is associated with inhibition of cuproptosis and proliferation of cancer-associated fibroblasts in oral squamous cell carcinoma: A potential mechanism for tumor metastasis [J]. Front Oncol, 2022, 12: 925743.
[11] Reed ER, Jankowski SA, Spinella AJ, et al. β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer [J]. Transl Res, 2023, 260: 46-60.
[12] Huynh NC, Huang TT, Nguyen CT, et al. Comprehensive integrated single-cell whole transcriptome analysis revealed the p-EMT tumor cells-CAFs communication in oral squamous cell carcinoma [J]. Int J Mol Sci, 2022, 23(12): 6470.
[13] Horny K, Sproll C, Peiffer L, et al. Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression [J]. J Transl Med, 2023, 21(1): 267.
[14] Liu YH, Chen YL, Lai TY, et al. Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues [J]. Front Oncol, 2021, 11: 769665.
[15] Hu S, Lu H, Xie W, et al. TDO2⁺ myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma [J]. J Clin Invest, 2022, 132(19): e157649.
[16] Gao F, Li C, Zhao X, et al. CKS2 modulates cell-cycle progression of tongue squamous cell carcinoma cells partly via modulating the cellular distribution of DUTPase [J]. J Oral Pathol Med, 2021, 50(2): 175-182.
[17] Glathar AR, Oyelakin A, Nayak KB, et al. A systemic and integrated analysis of p63-driven regulatory networks in mouse oral squamous cell carcinoma [J]. Cancers, 2023, 15(2): 446.
[18] Wang Z, Zhang H, Zhai Y, et al. Single-cell profiling reveals heterogeneity of primary and lymph node metastatic tumors and immune cell populations and discovers important prognostic significance of CCDC43 in oral squamous cell carcinoma [J]. Front Immunol, 2022, 13: 843322.
[19] Hu C, Fan J, He G, et al. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma [J]. PLoS One, 2022, 17(6): e0269166.
[20] Chen Z, Chen Q, Li S, et al. IL-12RB1: a novel immune prognostic biomarker for oral squamous cell carcinoma and linked to PD-1/PD-L1 expression in the tumor immune microenvironment [J]. Ann Transl Med, 2022, 10(3): 144.
[21] Meng Q, Wu F, Li G, et al. Exploring precise medication strategies for OSCC based on single-cell transcriptome analysis from a dynamic perspective [J]. Cancers, 2022, 14(19): 4801.
[22] Weusthof C, Burkart S, Semmelmayer K, et al. Establishment of a machine learning model for the risk assessment of perineural invasion in head and neck squamous cell carcinoma [J]. Int J Mol Sci, 2023, 24(10): 8938.
[23] Huang C, Liang Y, Dong Y, et al. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma [J]. Front Cell Dev Biol, 2022, 10: 884590.
[24] Han PZ, Tan LC, Ouyang QS, et al. Development and validation of a gene model predicting lymph node metastasis and prognosis of oral squamous cell carcinoma based on single-cell and bulk RNA-seq analysis [J]. J Oral Pathol Med. 2023, 52(5): 389-401.
[25] Wu L, Yang J, She P, et al. Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in oral squamous cell carcinoma cohort [J]. Front Oncol, 2023, 13: 1195520.
[26] Zhou L, Zeng Z, Egloff AM, et al. Checkpoint blockade-induced CD8⁺ T cell differentiation in head and neck cancer responders [J]. J Immunother Cancer, 2022, 10(1): e004034.
[27] Luoma AM, Suo S, Wang Y, et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy [J]. Cell, 2022, 185(16): 2918-2935.e29.
[28] Zhang S, Zhang W, Zhang J. 8-Gene signature related to CD8⁺ T cell infiltration by integrating single-cell and bulk RNA-sequencing in head and neck squamous cell carcinoma [J]. Front Genet, 2022, 13: 938611.
[29] He Y, Dong Y, Zhang X, et al. Lipid droplet-related PLIN2 in CD68⁺ tumor-associated macrophage of oral squamous cell carcinoma: Implications for cancer prognosis and immunotherapy [J]. Front Oncol, 2022, 12: 824235.
[30] Zhang B, Li H, Liu YT, et al. Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma [J]. Cancer Lett, 2023, 558: 216105.
[31] Galeano Niño JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer [J]. Nature, 2022, 611(7937): 810-817.
[32] Arora R, Cao C, Kumar M, et al. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response [J]. Nat Commun, 2023, 14(1): 5029.
[33] Liu Z, Zhang Z, Zhang Y, et al. Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma [J]. Int J Oral Sci, 2024, 16(1): 9.
[34] Zhi Y, Wang Q, Zi M, et al. Spatial transcriptomic and metabolomic landscapes of oral submucous fibrosis-derived oral squamous cell carcinoma and its tumor microenvironment [J]. Adv Sci (Weinh), 2024, 11(12):e2306515.
[35] Schmitd LB, Perez-Pacheco C, Bellile EL, et al. Spatial and transcriptomic analysis of perineural invasion in oral cancer [J]. Clin Cancer Res, 2022, 28(16): 3557-3572.
[36] Sun L, Kang X, Wang C, et al. Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma [J]. Cell Discov, 2023, 9(1): 28.
[37] Iwasa YI, Nakajima T, Hori K, et al. A spatial transcriptome reveals changes in tumor and tumor microenvironment in oral cancer with acquired resistance to immunotherapy [J]. Biomolecules, 2023, 13(12): 1685.